滤泡性B细胞淋巴瘤是一种非霍奇金淋巴瘤，肿瘤疫苗是治疗是根据肿瘤细胞的生物学特殊性。
The cancer vaccines rely on a biological quirk of follicular B-cell lymphoma, which is a type of non-Hodgkin's lymphoma.
随着分子生物学及基因工程技术的出现及应用，肿瘤疫苗的研究已成为主动性免疫治疗的重要手段之一。
The research on tumor vaccine has been a key method of tumor active immunotherapy with the development and application of molecular biological and genetic engineering technology.
目的探讨由动员人外周造血祖细胞体外培养扩增获得的树突状细胞(DC)的生物学特性，为临床应用肿瘤树突状细胞疫苗建立制备方法。
Objective to obtain dendritic cells (DCs) from peripheral blood stem cells and hematopoietic precursor cells in vitro, and assess the feasibility of clinical application of tumor vaccine.
目的探讨利用杂交瘤技术制备肿瘤疫苗的方法，研究肺癌树突状融合细胞的生物学特征。
Objective To explore the established method of tumor vaccine generated by hybrid technique and study the biological characteristics of lung cancer-dendritic fusion cell.
目的探讨利用杂交瘤技术制备肿瘤疫苗的方法，研究肺癌树突状融合细胞的生物学特征。
Objective To explore the established method of tumor vaccine generated by hybrid technique and study the biological characteristics of lung cancer-dendritic fusion cell.
应用推荐